Author:
Collange Fanny,Fressard Lisa,Pulcini Céline,Sebbah Rémy,Peretti-Watel Patrick,Verger Pierre
Funder
Directorate of Research, Studies, Evaluation and Statistics (DREES)/Ministry of Social Affairs and Health
National Institute for Prevention and Education in Health
French National Health Insurance Fund for Employees
French Directorate General of Health (DGS)
Arc Foundation for Cancer Research
French National Cancer Institute (INCa)
INPES
French National Institute of Health and Medical Research (INSERM)
French Interdepartmental Agency for the Fight against Drugs and Addictive Behaviors (Mildeca)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference50 articles.
1. Introduction of HPV Vaccines in European Union Countries – An Update;European Centre for Disease Prevention and Control,2012
2. Voluntary school-based human papillomavirus vaccination: an efficient and acceptable model for achieving high vaccine coverage in adolescents;Skinner;J Adolesc Health,2010
3. Institut de Veille Sanitaire. Dossier thématique: vaccin HPV 2015. http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Couverture-vaccinale/Donnees/Papillomavirus-humains [Accessed 12.12.15].
4. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years — United States, 2014;CDC;Morb Mortal Wkly Rep,2015
5. Factors associated with HPV vaccine uptake in teenage girls: a systematic review;Kessels;Vaccine,2012